ICD Co., Ltd. announced that it expects to receive KRW 25 billion in funding from NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd, Kiwoomfni Co., Ltd., Shinhan Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd.
April 23, 2024
Share
ICD Co., Ltd announced a private placement to issue Series 5 Bearer-bearing interest-bearing, unsecured private placement convertible bonds for a gross proceeds KRW 25,000,000,000 on April 24, 2024. The transaction includes participation from Shinhan Investment & Securities Co., Ltd., Kiwoomfni Co., Ltd., Hanyang Securities Co., Ltd, KB Securities Co., Ltd., Mirae Asset Securities Co., Ltd. NH Investment & Securities Co., Ltd, Samsung-Rhinos Mezzanine New Technology Fund No. 1, JB-Rhinos Mezzanine New Technology Fund and Hanyang Time Mezzanine New Technology Fund.
The Notes bear interest rate of zero percent and matures on April 26, 2029. The notes are convertible into 2,726,578 shares with a conversion price of KRW 9,169 per share representing conversion rate of 14.32%. Conversion claim period is April 26, 2025 to March 26, 2029.
The transaction has been approved by the board of directors of the company. The transaction is expected to close on April 26, 2024.
HANYANG SECURITIES CO., Ltd. is a Korea-based company engaged in the financial business. The Company operates securities dealing business, including stocks, bonds, promissory notes, foreign currency securities, futures, options and others; entrust buying and selling business; securities underwriting business, including initial public offering (IPO), stocks, national bonds and public bonds, corporate bonds, foreign currency securities and others; credit offering business; discretionary investment business, and bond transaction with repurchase agreements dealing business.